Sign in
4

Changes in Ownership

COLLEGIUM PHARMACEUTICAL, INC Filed Acc 0001062993-25-014526

EVP & Chief Commercial Officer sold 4,861 shares at $38.03 ($184,881)

  • EVP & Chief Commercial Officer acquired 4,861 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Dreyer Scott · EVP & Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-13 Exercise or conversion : show line 1 in the form 10b5-1 +4,861 $21.34 $103,734 108,474 D
2025-08-13 Sale : show line 2 in the form 10b5-1 −4,861 $38.03 $184,881 103,613 D
Open-market sales · 4,861 sh · avg $38.03 · $184,881

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-13 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Purchase) −4,861 16,389 D
Loading xslF345X05/form4.xml…